Pandemic Influenza Preparedness And Response Plan

Objectives

Provide a dynamic national framework for Trinidad and Tobago to prepare for, respond to and recover from pandemic influenza, minimising serious illness, deaths and societal disruption through coordinated action across health, emergency and community systems.[1][2][3]The Plan is organised around World Health Organization pandemic phases and covers the inter-pandemic, pandemic and post-pandemic periods, allowing activities to escalate, adapt to local epidemiology and be revised as circumstances change.[4][5][6]

• Strengthen integrated virologic and disease surveillance to detect novel strains, identify high-risk groups, monitor disease intensity and progression, and guide prevention and control measures.[7][8]
• Provide equitable, prioritised access to pandemic vaccines and antiviral medicines, recognising likely early supply constraints, the potential need for two vaccine doses, and the need to protect health workers, essential-service personnel and people at higher risk of severe outcomes.[9][10][11][12]
• Maintain health-system continuity by expanding surge capacity, preserving essential services, managing scarce staff, beds, medicines and equipment, and using non-traditional care sites where conventional services are overwhelmed.[13][14][15][16]
• Reduce transmission through infection prevention and control, public-health measures, risk communication, hygiene, isolation or cohorting, and locally appropriate restrictions on gatherings and movement.[17][18][19][20]
• Support recovery after pandemic waves by restoring routine services, reviewing outcomes and lessons learnt, revising plans, and undertaking post-pandemic evaluation, including socio-economic considerations.[2][21][22][23]

Implementation

Implementation relies on a phased, all-of-government and all-of-society emergency-management model led by the Ministry of Health and coordinated with the Office of Disaster Preparedness and Management, Regional Health Authorities, local health authorities, emergency services, laboratories, health-care providers, other ministries, private-sector bodies and community partners.[24][25][26]The Pandemic Influenza Committee serves as the principal inter-ministerial coordination mechanism, advising on activation, priorities, equitable allocation, surveillance, communications and preparedness actions.[24][26][27]

• Coordinate national surveillance, international liaison, technical guidance, laboratory functions, vaccine and antiviral procurement, plan maintenance and emergency mobilisation through the Ministry of Health.[26]
• Deliver regional and local prevention, treatment, outbreak investigation, reporting, emergency coordination and community health-promotion functions through Regional Health Authorities and local agencies.[27][21]
• Operate laboratory surveillance through the Trinidad and Tobago Public Health Laboratory, National Surveillance Unit, regional laboratories, the Caribbean Epidemiology Centre and international reference partners, using routine and enhanced testing, subtyping, susceptibility testing and rapid communication.[7][28][29]
• Use documented triggers, including local disease epidemiology, emergency-department demand, hospital capacity, ambulance diversion and reports that services cannot accommodate demand, to activate surge measures and non-traditional sites.[30][31][32]
• Expand care through triage centres, alternative clinics, temporary influenza hospitals, home support, long-term-care arrangements and linked non-traditional sites, while reserving acute and critical-care capacity for patients requiring specialised treatment.[33][34][35][16]
• Mobilise and support health workers, retirees, trainees, volunteers and essential-service personnel through workforce databases, role-specific training, reassignment arrangements, licensing and insurance review, occupational-health protections and family or psychosocial support.[36][37][38][39]
• Maintain operational readiness through stockpiling, supplier planning, inventories, emergency equipment, communications systems, simulation exercises and periodic plan revision, while recognising risks from disrupted imports, transport constraints and staff absenteeism.[25][40][41][42]
• Monitor implementation through routine and enhanced surveillance, vaccine and antiviral safety reporting, resistance monitoring, capacity tracking, exercise results, response documentation and post-pandemic reviews; the source does not provide a single consolidated national indicator set, reporting timetable or quantified budget.[25][6][41][43]

Monitoring & Evaluation

The Plan establishes a phased monitoring and response model for pandemic influenza, integrating surveillance, laboratory testing, clinical reporting, health-service capacity tracking, vaccine and antiviral safety monitoring, exercises and post-pandemic review. Monitoring is intended to guide escalation, adaptation of measures and restoration of routine services across inter-pandemic, pandemic and recovery periods.[25][21][6][22]

• Maintain routine and enhanced influenza surveillance, including influenza-like illness, hospitalisations, deaths, unusual events, circulating variants, high-risk populations and outbreak intensity.[25][21][7]
• Combine epidemiological and virologic surveillance to identify novel strains, antigenic or genetic changes, transmission patterns, antiviral resistance and the ability of variants to cause disease.[21][7][8]
• Use local, regional and national reporting channels, with suspected cases reported through health services to County Medical Officers of Health and surveillance information analysed by the National Surveillance Unit.[7]
• Use laboratory systems for virus typing, subtyping, susceptibility testing, proficiency assessment and rapid communication of results to submitting laboratories and relevant health authorities.[28][29][44]
• Track pandemic progression through World Health Organization phases, evidence of human-to-human transmission, geographical spread, morbidity, mortality, case-fatality rates and local service pressures.[4][29][45]
• Monitor vaccine coverage, receipt of one or two doses, vaccine-associated adverse events, effectiveness and priority-group needs as epidemiological evidence develops.[27][9][10][6]
• Monitor antiviral supply, distribution, diversion, uptake, wastage, adverse reactions, effectiveness and resistance, and revise treatment and prophylaxis priorities as evidence changes.[46][47][48]
• Track operational capacity through hospital wards, intensive-care beds, oxygen, ventilators, staffing, emergency-department demand, ambulance diversion, alternative-site capacity and supply inventories.[33][30][41][49]
• Use predefined local triggers, such as influenza-related emergency visits, hospitalisation levels, constrained hospital capacity and unaccommodated demand reported by sentinel clinicians, to activate phased response measures and non-traditional care sites.[30][31][32]
• Conduct simulation exercises, laboratory disaster drills, plan testing and periodic review to assess preparedness and identify changes required.[25][18][29][40]
• Assign oversight roles to the Pandemic Influenza Committee, Ministry of Health, Regional Health Authorities, local health authorities, laboratory and surveillance bodies, and facility-level infection-control leads.[24][25][26][50]
• Undertake post-pandemic evaluation of disease burden, response performance, social and economic effects, institutional roles and lessons learnt, with recommendations communicated to relevant stakeholders.[21][5][6][22]

Although the Plan identifies extensive surveillance, documentation and review mechanisms, many sections do not specify a consolidated national indicator set, reporting timetable, audit process, performance targets or sanctions for non-compliance.[25][40][6][29]

Costing & Financing

The Plan is resource-focused rather than costed: it identifies major requirements for surveillance, laboratory capacity, vaccines, antivirals, infection control, surge beds, workforce mobilisation, non-traditional sites, emergency stockpiles, transport and mass-fatality services, but generally provides no monetary budget, financing source, allocation, funding gap or economic assumptions.[25][40][15][51]

• Require national, regional and local health levels to develop cost estimates and options for decision-makers, including arrangements for vaccine infrastructure, allocation, management and funding.[25]
• Recognise the potential health and economic effects of a pandemic and use speculative estimates of infections, outpatient visits, hospitalisations and deaths to inform public-health and emergency-sector planning.[52][53]
• Plan for constrained international supplies of vaccines, antivirals, medicines, equipment and medical materials, particularly because Trinidad and Tobago does not produce vaccines and has limited domestic medicine production.[9][54][15]
• Prepare for vaccine demand through an order for 26,000 seasonal influenza doses for high-risk groups and a planning requirement for at least three million pandemic vaccine doses, including a monthly delivery requirement of 750,000 doses.[9][10]
• Mobilise resources for stockpiling, including mobile hospital beds, syringes, medical supplies, antivirals, vaccines, emergency equipment and support for people confined at home.[25][40][23]
• Address supply-chain vulnerabilities arising from just-in-time inventories, transport disruption, import dependence, possible export embargoes and a potential loss of up to 30% of transport-related workers.[41][55]
• Plan resource allocation across hospitals, vaccination clinics, triage centres, long-term care, home care and non-traditional sites, including personnel, beds, ventilators, oxygen, medicines, communications and transport.[14][15][56]
• Use the National Emergency Stockpile System to purchase, package, ship, store and distribute emergency medical and social-service supplies, with Ministry of Health equipment made available to local and regional bodies on a loan basis.[57][31]
• Consider financial arrangements for municipalities, salaries or payments for temporary personnel, compensation for requisitioned property, insurance, workers’ compensation, volunteer support and workforce training.[58][59][60][61]
• Recognise selected economic considerations, including higher costs of neuraminidase inhibitors than amantadine, increasing costs of medical interventions, and avoidable additional costs from water-soluble laundry bags without infection-control benefit.[48][62][63]

No comprehensive costing methodology, approved pandemic budget, funding-gap estimate, donor or financing plan, unit-cost schedule, or currency-denominated expenditure programme is specified in the supplied material.[25][58][42]